IRX Therapeutics Garners $1,500,000 New Round

  • Feed Type
  • Date
    5/31/2012
  • Company Name
    IRX Therapeutics
  • Mailing Address
    140 West 57th Street New York, NY 10019
  • Company Description
    IRX Therapeutics’ mission is to discover and commercialize drugs that stimulate a coordinated TH1-specific cellular immune response to treat human diseases. This immune response is essential for the eradication of most viruses and tumors, and relies on the effective functioning of dendritic cells, macrophages, and T-cells.
  • Website
    http://www.irxtherapeutics.com
  • Transaction Type
    Debt
  • Transaction Amount
    $1,500,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed. SEC regulatory filing.
  • M&A Terms
  • Venture Investor
    Undisclosed